Astromech — Valuation, Funding & Investors

We're still building this profile — here is what Pulse has covered.

Recent changes

Aug 20, 2026Aug 20, 2026Colossal Spinout Astromech Hits $3.8B on Biology AI Pulse story

Latest Pulse

Aug 20, 2026Colossal Spinout Astromech Hits $3.8B on Biology AIAstromech, a Colossal Biosciences spinout co-founded by Ben Lamm and George Church, raised $20M at a $3.8B valuation to build AI models that predict evolutionary biological change.→

Coverage Timeline

newest first

Aug 20, 2026FUNDINGColossal Spinout Astromech Hits $3.8B on Biology AI$20M at $3.8B→

All Coverage

FUNDING· Aug 20, 2026

Colossal Spinout Astromech Hits $3.8B on Biology AI

FUNDING$20M at $3.8B

Colossal Spinout Astromech Hits $3.8B on Biology AI

Astromech, a Colossal Biosciences spinout co-founded by Ben Lamm and George Church, raised $20M at a $3.8B valuation to build AI models that predict evolutionary biological change.

Aug 20, 2026DEEP DIVE

Related Companies

Same sector

Attovia Therapeutics Apnimed Braveheart Bio Latigo Biotherapeutics Scribe Therapeutics